Bruton's Tyrosine Kinase Inhibitors [MoA] - N0000193934

Pharmacologic Class Information

Pharmacologic Code N0000193934
Pharmacologic Name Bruton's Tyrosine Kinase Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Bruton's Tyrosine Kinase Inhibitors

The following table contains 1 products whose active ingredient are classified under the same pharmacologic class Bruton's Tyrosine Kinase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
72579-011Brukinsa Non-Proprietary Name: ZanubrutinibCapsuleOralBeigene Usa, Inc.ACTIVE